KOCAA
Knights of Columbus Asset Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.39M | Buy |
4,603
+736
| +19% | +$223K | 0.08% | 228 |
|
|
2025
Q1 | $1.28M | Sell |
3,867
-828
| -18% | -$274K | 0.09% | 222 |
|
|
2024
Q4 | $1.45M | Buy |
4,695
+2,116
| +82% | +$653K | 0.1% | 221 |
|
|
2024
Q3 | $547K | Sell |
2,579
-2,667
| -51% | -$566K | 0.04% | 267 |
|
|
2024
Q2 | $1.47M | Buy |
5,246
+83
| +2% | +$23.3K | 0.1% | 234 |
|
|
2024
Q1 | $1.38M | Sell |
5,163
-3,532
| -41% | -$943K | 0.1% | 232 |
|
|
2023
Q4 | $2.01M | Buy |
8,695
+4,386
| +102% | +$1.01M | 0.13% | 230 |
|
|
2023
Q3 | $629K | Buy |
4,309
+74
| +2% | +$10.8K | 0.06% | 262 |
|
|
2023
Q2 | $978K | Buy |
4,235
+3,655
| +630% | +$844K | 0.09% | 246 |
|
|
2023
Q1 | $141K | Buy |
+580
| New | +$141K | 0.01% | 318 |
|